Zenzero and colitis: the active compound that “closes” the barrier

The anti-inflammatory action that starts from the barrier: what changes with FDN There comes a moment, when talking about the gut, when words stop being enough. “Bloating”, “irritation”, “inflammation”: useful labels, but too broad to guide a choice. That’s where research becomes truly interesting: when it takes a familiar ingredient and breaks it down until…